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INtRODuCtION
Tuberculosis (TB) is a bacterial infection caused by Mycobaterium tuberculosis. TB has recently 
reemerged as a disease of interest for improved drug delivery, with a focus on leveraging the 
benefits of anti-tubercular drug nanoparticle formulation (1, 2). Drug nanoparticles can target 
infected cells and provide a large payload, but the optimal administration route remains uncertain 
(3). While oral formulations are most preferred, the passage of nanoparticles across the gastro-
intesintal tract is challenging. On the other hand, intravenous injection of nanosuspensions is 
invasive (4). Alternatively, dry powder aerosols have the stability of a solid dosage form and their 
delivery is noninvasive. Local drug targeting to the lungs also lowers the dose and systemic adverse 
effects. It is therefore desirable to produce inhalable powders comprised of a biocompatible matrix 
containing high loadings of drug nanoparticles. The present work provides a new understanding 
of the production of inhalable particles by ultrasonic spray freeze drying to enable precise control 
over particle density and aerodynamic properties.
MEtHODS
A series of highly porous mannitol, lysozyme, or bovine serum albumin (BSA) particles were 
produced by spray freeze drying aqueous solutions of the compounds using a CV-24 ultrasonic 
nozzle powered by a Vibra Cell 40 kHz ultrasonic generator (Sono-Tek Corp. Milton, NY, USA) 
at a liquid flow rate of 0.5 mL/min. The solute concentration of the solutions was varied from 
696 Spray Freeze Dried Large Porous Particles for Nano Drug Delivery by Inhalation – D’Addio et al.
10-50 mg/mL to obtain particles with the same geometric diameter but different porosity. The 
solutions were injected through the nozzle at 0.5 mL/min by a PHD 2000 syringe pump (Harvard 
Apparatus, Holliston, MA, USA). The atomized droplets fell by gravity over 3-10 cm and were 
collected in a container of liquid nitrogen. The frozen droplets were freeze dried at 25°C for 18 h 
(for mannitol) or first maintained at -25°C for 48 h and then at 20°C for 24 h (for BSA and 
lysozyme). The particle size distribution was determined by laser diffraction (Mastersizer 2000; 
Malvern, Worcestershire, UK). In vitro aerosol performance was measured by dispersing 2.5-5.0 mg 
of a powder from an Aerolizer® (Novartis, North Ryde, NSW, Australia) into a Next Generation 
Impactor (NGI) at 100 L/min.
Cholesterol nanoparticles (Sigma, St. Louis, MO, USA) stabilized by poly(ethylene 
glycol)-block-polylactide (PEG5k-b-PLA3.8k; Surmodics, Birmingham, AL, USA) were prepared 
by anti-solvent precipitation in a confined impinging jets mixer. The nanoparticles were sized 
by dynamic light scattering (ZetaSizer Nano ZS; Malvern Instruments, Worcestershire, UK). 
Cholesterol was employed as a model hydrophobic compound. A 1:1 mixture by weight of man-
nitol to nanoparticles at 20 mg/mL total solids concentration in deionized water was spray freeze 
dried as described above to obtain large porous particles loaded with cholesterol nanoparticles. The 
powder aerosol performance was determined by dispersion into the NGI.
RESuLtS
Large porous particles were produced from spray freeze drying of all three compounds (Figure 1). 
The particle sizes of mannitol, BSA, and lysozyme powders were essentially independent of solute 
concentration when produced from the same ultrasonic nozzle. Both mannitol and lysozyme 
formulations showed a linear relationship between the fine particle fraction (FPF) (mass fraction 
of the loaded dose with aerodynamic diameter ≤ 5 µm) and the square root of solute concentration 
(Cs), which is proportional to the particle density (ρ), when geometric particle diameter is constant 
(dg) (Figure 3). Due to cohesion, the FPF for BSA was < 10% and independent of Cs.
Figure 1.  SEM images of large porous particles prepared from spray freeze drying aqueous solutions at 
(a) 10 mg/mL, (b) 20 mg/mL, (c) 40 mg/mL, and (d) 50 mg/mL.
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Figure 2.  Volume-weighted size distributions for each particle formulation, prepared from aqueous solutions 
of a) mannitol, b) BSA, and c) lysozyme at 10 mg/mL (n), 20 mg/mL (o), 40 mg/mL (l), 
and 50 mg/mL(¢).
Figure 3.  FPF of large porous (n) mannitol, (o) lysozyme, and (l) BSA plotted against the square root of 
aqueous solution concentration.
The intensity-weighted Z-average diameter of the cholesterol nanoparticles was 82 nm. 
Large porous mannitol particles with a 50% nanoparticle loading yielded a FPF of 63%.
698 Spray Freeze Dried Large Porous Particles for Nano Drug Delivery by Inhalation – D’Addio et al.
CONCLuSIONS
Ultrasonic spray freeze drying enabled separate control over particle size and aerodynamic size (da). 
This allowed us to make the first experimental demonstration of the widely accepted relationship 
for spherical particles,  
Equation 1
(ρ0 = unit density), by varying the particle density rather than the geometric diameter. Large porous 
mannitol particles with a high nanoparticle loading (50% by mass) showed excellent aerosol per-
formance. Thus, spray freeze drying may be a feasible technique for formulating powders to deliver 
drug nanoparticles into the lungs.
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